Genius Sports Raises Full-Year Guidance Significantly Post-Legend Acquisition
summarizeSummary
Genius Sports reported strong Q1 revenue and Adjusted EBITDA growth, and significantly raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and margin, following the completion of the Legend acquisition.
check_boxKey Events
-
Q1 2026 Financial Results
Revenue increased 31% year-over-year to $188.0 million, and Adjusted EBITDA grew 21% to $24.0 million. However, the net loss widened to $(55.5) million, primarily due to foreign currency movements, stock-based compensation, and one-time Legend transaction expenses.
-
Full-Year 2026 Guidance Significantly Raised
Full-year 2026 Group Revenue guidance was raised to $990 million - $1.01 billion (from $810 million - $820 million previously). Full-year 2026 Group Adjusted EBITDA guidance was increased to $270 million - $280 million (from $180 million - $190 million previously).
-
Adjusted EBITDA Margin Target Increased
The full-year 2026 Group Adjusted EBITDA Margin target was raised from approximately 23% to 28% at the midpoint.
-
Legend Acquisition Drives Outlook
The raised guidance is attributed to the successful completion of the Legend acquisition on April 30, 2026, which involved $800 million in cash and 10,088,781 ordinary shares. This strategic move is expected to accelerate financial objectives and enhance fan monetization.
auto_awesomeAnalysis
Genius Sports reported strong Q1 revenue and Adjusted EBITDA growth, and significantly raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and margin, following the completion of the Legend acquisition. The substantial increase in guidance, particularly the 51% rise in Adjusted EBITDA at the midpoint, signals a strong positive outlook for the company's future performance and the strategic benefits of the acquisition. While the net loss widened in Q1, the company attributes this to non-recurring factors like foreign currency movements and transaction expenses related to the acquisition. The new financing arrangements provide the capital structure to support this expanded operation.
At the time of this filing, GENI was trading at $4.55 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $3.83 to $13.73. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.